Replies to post #3930 on RedHill Biopharma Ltd (RDHL)

[midastouch017]

"Opaganib, which acts as a sphingosine competitor, is the first
clinical drug to target three key enzymes in this pathway."

Great news once it gets into the market!
What RDHL urgently needs is some steady
$$$ revenue stream!